Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marja-Riitta Taskinen

Showing results (31-40 of 230) with videos related to

Pageof 23
Sort By:
Mediators of Inflammation|September 5, 2006
ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjectsJuhani Kahri, Aino Soro-Paavonen, Christian Ehnholm, et al.
Current Opinion in Lipidology|May 9, 2006
Diabetic dyslipidaemiaMartin Adiels, Sven-Olof Olofsson, Marja-Riitta Taskinen, et al.
European Journal of Endocrinology|August 18, 2006
Blockade of oestrogen biosynthesis in peripubertal boys: effects on lipid metabolism, insulin sensitivity, and body compositionMatti Hero, Carina Ankarberg-Lindgren, Marja-Riitta Taskinen, et al.
Metabolism: Clinical and Experimental|March 9, 2010
Increased apolipoprotein E level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndromeSanni Söderlund, Hiroshi Watanabe, Christian Ehnholm, et al.
BMC Systems Biology|January 22, 2013
A continuous-time adaptive particle filter for estimations under measurement time uncertainties with an application to a plasma-leucine mixed effects modelAnnette Krengel, Jan Hauth, Marja-Riitta Taskinen, et al.
Plos One|October 1, 2015
Improved Estimation of Human Lipoprotein Kinetics with Mixed Effects ModelsMartin Berglund, Martin Adiels, Marja-Riitta Taskinen, et al.
Diabetes/Metabolism Research and Reviews|December 7, 2002
Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetesJuha Vakkilainen, Niina Mero, Anja Schweizer, et al.
Current Atherosclerosis Reports|February 16, 2026
Apolipoprotein C-III: Risk-factor, Regulator of Triglyceride-rich Lipoprotein Metabolism and Therapeutic TargetElias Björnson, Martin Adiels, Marja-Riitta Taskinen, et al.
Journal of Lipid Research|May 18, 2005
Hypertriglyceridemia is associated with prebeta-HDL concentrations in subjects with familial low HDLSanni Söderlund, Aino Soro-Paavonen, Christian Ehnholm, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS)Jean-Claude Ansquer, Christelle Foucher, Stephanie Rattier, et al.
Pageof 23

Showing results (31-40 of 230) with videos related to

Sort By:
Pageof 23
Mediators of Inflammation|September 5, 2006
ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjectsJuhani Kahri, Aino Soro-Paavonen, Christian Ehnholm, et al.
Current Opinion in Lipidology|May 9, 2006
Diabetic dyslipidaemiaMartin Adiels, Sven-Olof Olofsson, Marja-Riitta Taskinen, et al.
European Journal of Endocrinology|August 18, 2006
Blockade of oestrogen biosynthesis in peripubertal boys: effects on lipid metabolism, insulin sensitivity, and body compositionMatti Hero, Carina Ankarberg-Lindgren, Marja-Riitta Taskinen, et al.
Metabolism: Clinical and Experimental|March 9, 2010
Increased apolipoprotein E level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndromeSanni Söderlund, Hiroshi Watanabe, Christian Ehnholm, et al.
BMC Systems Biology|January 22, 2013
A continuous-time adaptive particle filter for estimations under measurement time uncertainties with an application to a plasma-leucine mixed effects modelAnnette Krengel, Jan Hauth, Marja-Riitta Taskinen, et al.
Plos One|October 1, 2015
Improved Estimation of Human Lipoprotein Kinetics with Mixed Effects ModelsMartin Berglund, Martin Adiels, Marja-Riitta Taskinen, et al.
Diabetes/Metabolism Research and Reviews|December 7, 2002
Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetesJuha Vakkilainen, Niina Mero, Anja Schweizer, et al.
Current Atherosclerosis Reports|February 16, 2026
Apolipoprotein C-III: Risk-factor, Regulator of Triglyceride-rich Lipoprotein Metabolism and Therapeutic TargetElias Björnson, Martin Adiels, Marja-Riitta Taskinen, et al.
Journal of Lipid Research|May 18, 2005
Hypertriglyceridemia is associated with prebeta-HDL concentrations in subjects with familial low HDLSanni Söderlund, Aino Soro-Paavonen, Christian Ehnholm, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS)Jean-Claude Ansquer, Christelle Foucher, Stephanie Rattier, et al.
Pageof 23